Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies
NA-PHER2 试验中接受 HER2 靶向和内分泌治疗的 HER2+ER+ 乳腺癌的疗效和分子动力学决定因素
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-025-57293-9
Maurizio Callari, Matteo Dugo, Marco Barreca, Balázs Győrffy, Barbara Galbardi, Lucia Vigano, Alberta Locatelli, Chiara Dall'Ara, Marina Ferrarini, Giancarlo Bisagni, Marco Colleoni, Mauro Mansutti, Claudio Zamagni, Lucia Del Mastro, Stefania Zambelli, Antonio Frassoldati, Olivia Biasi, Lajos Puszta
